Houston, TX -- (SBWIRE) -- 01/30/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
BioClinica Inc (NASDAQ:BIOC) is higher 19.37% and is trading at $7.21. BioClinica, Inc. (BioClinica) provides integrated clinical research technology solutions to pharmaceutical, biotechnology, and medical device companies, and other organizations, such as contract research organizations (CRO), which is engaged in global clinical studies. The Company’s products and services include medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools and clinical trial management software solutions.
Can BIOC Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Gevo, Inc. (NASDAQ:GEVO) is lower 8.36% and is trading at $2.18. Gevo, Inc., is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol, maintaining and protecting its intellectual property portfolio, developing future markets for its isobutanol and providing corporate oversight services.
How Should Investors Trade GEVO After The Recent Volatile Moves? Find Out Here
Penn Virginia Corporation (NYSE:PVA) fell 1.17% and is trading at $4.23. Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company primarily engaged in the exploration, development and production of natural gas and oil in various domestic onshore regions of the United States, including Texas, Appalachia, the Mid-Continent and Mississippi. Its operations include primarily unconventional developmental drilling opportunities and exploratory prospects. As of December 31, 2011, the Company’s proved reserves were approximately 883 billions of cubic feet equivalent (Bcfe).
Is PVA Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
NewLink Genetics Corp (NASDAQ:NLNK) is higher 3.86% and is trading at $11.84. NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians. Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast cancer.
Can NLNK Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
XOMA Corporation (NASDAQ:XOMA) is lower 2.99% and is trading at $2.60. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinical pipeline includes classes of antibodies that activate or sensitize the insulin receptor in vivo, named XMet, and represent potential new therapeutic approaches to the treatment of diabetes and several diseases that have insulin involvement.
Is XOMA Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)